These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11156753)

  • 1. Placebo-controlled study of divalproex sodium for agitation in dementia.
    Porsteinsson AP; Tariot PN; Erb R; Cox C; Smith E; Jakimovich L; Noviasky J; Kowalski N; Holt CJ; Irvine C
    Am J Geriatr Psychiatry; 2001; 9(1):58-66. PubMed ID: 11156753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divalproex sodium therapy in elderly with dementia-related agitation.
    Pratt CE; Davis SM
    Ann Pharmacother; 2002 Oct; 36(10):1625-8. PubMed ID: 12243614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.
    Tariot PN; Raman R; Jakimovich L; Schneider L; Porsteinsson A; Thomas R; Mintzer J; Brenner R; Schafer K; Thal L; ;
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):942-9. PubMed ID: 16286437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate therapy for agitation in dementia: open-label extension of a double-blind trial.
    Porsteinsson AP; Tariot PN; Jakimovich LJ; Kowalski N; Holt C; Erb R; Cox C
    Am J Geriatr Psychiatry; 2003; 11(4):434-40. PubMed ID: 12837672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.
    Tariot PN; Erb R; Podgorski CA; Cox C; Patel S; Jakimovich L; Irvine C
    Am J Psychiatry; 1998 Jan; 155(1):54-61. PubMed ID: 9433339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose divalproex in agitated patients with Alzheimer's disease.
    Dolder C; McKinsey J
    J Psychiatr Pract; 2010 Jan; 16(1):63-7. PubMed ID: 20098234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of divalproex sodium in the treatment of agitation associated with major depression.
    Debattista C; Solomon A; Arnow B; Kendrick E; Tilston J; Schatzberg AF
    J Clin Psychopharmacol; 2005 Oct; 25(5):476-9. PubMed ID: 16160625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid treatment of agitation in dementia.
    Herrmann N
    Can J Psychiatry; 1998 Feb; 43(1):69-72. PubMed ID: 9494750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitated symptom response to divalproex following acute brain injury.
    Chatham Showalter PE; Kimmel DN
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):395-7. PubMed ID: 10956575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances.
    Kunik ME; Puryear L; Orengo CA; Molinari V; Workman RH
    Int J Geriatr Psychiatry; 1998 Jan; 13(1):29-34. PubMed ID: 9489578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial.
    Sival RC; Haffmans PM; Jansen PA; Duursma SA; Eikelenboom P
    Int J Geriatr Psychiatry; 2002 Jun; 17(6):579-85. PubMed ID: 12112183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
    Suppes T; Vieta E; Gustafsson U; Ekholm B
    Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate in the treatment of behavioral agitation in elderly patients with dementia.
    Lott AD; McElroy SL; Keys MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):314-9. PubMed ID: 7580190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia.
    Meinhold JM; Blake LM; Mini LJ; Welge JA; Schwiers M; Hughes A
    Drugs Aging; 2005; 22(7):615-26. PubMed ID: 16038575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
    Olson DA; Ingram W; Mann JR
    J Clin Psychopharmacol; 2002 Oct; 22(5):529-30. PubMed ID: 12352281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.